|
Match
|
Document |
Document Title |
|
|
6291433 |
Derivatives of α-D-Thioxyloside and their use against atheroma
The present invention concerns, as new industrial products, the α-D-xylose compounds of formula I: ##STR1## wherein X and Y represent, independently of one another, an oxygen atom or a sulphur...
|
|
|
6284744 |
Peritoneal induced medicaments
A solution of hyaluronic acid and water-soluble salts thereof in a pharmaceutically acceptable media in which the hyaluronic acid concentration is at least about 0.4% by weight based on the weight...
|
|
|
6264913 |
Non-invasive test for assessing bacterial overgrowth of the small intestine
Provided herein is a novel breath test for assessing bacterial overgrowth. The test involves administration of a labeled sorbitol or sorbitol derivative to a subject and measurement of the label in...
|
|
|
6258784 |
Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
This invention provides smooth muscle cell proliferation inhibitors of formula I having the structure ##STR1## wherein W is S, SO, SO 2 , NR; Y is O, S, NR, or CH 2 ; R is hydrogen or...
|
|
|
6235709 |
Inhibitor of helicobacter pylori colonization
The present invention provides a safe and effective inhibitor of Helicobacter pylori colonization in the stomach and a food containing the inhibitor. The inhibitor of the present invention...
|
|
|
6224891 |
Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions
This invention relates to the treatment of diarrhea and related conditions caused by pathogenic E. coli infection. More specifically, this invention is drawn to the unexpected discovery that by...
|
|
|
6221350 |
Enhancement of microbial colonisation of the gastrointestinal tract
Probiotic composition comprising one or more probiotic microorganisms, a carrier which will function to transport the one or more probiotic microorganisms to the large bowel or other regions of the...
|
|
|
6194393 |
Solution and solid-phase formation of glycosidic linkages
The invention relates to methods that permit the rapid construction of oligosaccharides and other glycoconjugates. Methods for forming multiple glycosidic linkages in solution in a single step are...
|
|
|
6187768 |
Kit for flushing medical devices and method of preparation
A kit and for flushing a medical device a method of preparing the kit is disclosed. The kit includes a container containing a mixed solution a unit dose of a pharmacologically effective amount of...
|
|
|
6187762 |
Polyvalent polymers for the treatment of rotavirus infection
The present invention includes polymerizable monomers comprising a fucoside moiety. In one embodiment, the monomer has a polymerizable functional group, such as an olefinic bond, to which the...
|
|
|
6147054 |
Composition for cosmetic, pharmaceutical or dietetic use based on an amino sugar and/or a polyhydroxylic acid
A composition for cosmetic, pharmaceutical or dietetic use and including as the active ingredient, at least one of the substances which include acetylglucosamine and glucuronic acid in combination...
|
|
|
6143730 |
Preparation and use of sulfated oligosaccharides
Sulfated oligosaccharides, wherein the oligosaccharide has the general formula I: R 1 --(R x ) n --R 2 (I) wherein R 1 and R 2 and each R x represents a...
|
|
|
6124266 |
Sulpholipid composition and methods for treating skin disorders
The invention refers to the use of a sulpholipid SQDG having formula (I), wherein R 1 and R 2 , which are the same or different, are hydrogen or saturated or unsaturated, optionally...
|
|
|
6117843 |
Compositions for the treatment of acne containing clindamycin and benzoyl peroxide
A pharmaceutical composition containing clindamycin and benzoyl peroxide is disclosed for the treatment of acne. The composition is stable for several months when stored at room temperature....
|
|
|
6103768 |
Fatty acid based compositions and methods for the control of plant infections and pests
The invention described here concerns the unique utility of fatty acids and their derivatives to eradicate existing fungal and bacterial infections in plants. Also, described herein are combination...
|
|
|
6087339 |
Saccharide derivatives
Disclosed are novel saccharide derivatives which inhibit binding of toxins, such as heat-labile enterotoxin or cholera toxin, to their receptors either in vitro or in vivo. Additionally, disclosed...
|
|
|
6080726 |
Anti-viral and immuno stimulator polynucleotide duplex and use thereof
A method of treating HSV-2 infection which comprises administering to a host subject to said infection an effective amount of a polynucleotide of the formula polyrI.polyr(C 12 U) where n is an...
|
|
|
6075010 |
Small molecular weight ligand-hexose containing clearing agents
Small molecule weight clearing agents containing ligands such as biotin or biotin analogs and hexose residue, in particular galactose or N-acetyl galactosamine residues are taught. These clearing...
|
|
|
6063769 |
1-thiogalactose derivatives
Disclosed are novel 1-thiogalactose derivatives which inhibit binding of heat labile toxin (LT) and/or chlorea toxin (CT) to cell surface receptors either in vitro or in vivo. Additionally,...
|
|
|
6013634 |
Solid support matrices containing a toxin binding oligosaccharide
Disclosed are novel solid support matrices having a toxin-binding oligosaccharide covalently attached to a solid support through a linking arm which has at least 5 atoms separating the...
|
|
|
5998367 |
Pramlintide pro H-amylin salts and compositions
Agonist analogues of amylin and related pharmaceutical compositions, and methods of treatment of diabetes and other insulin-requiring states, as well as methods of treatment of hypoglycemia, are...
|
|
|
5989592 |
Inhibition of complement pathway by sea cucumber fractions
The present invention relates to methods for inhibiting the complement pathway in a mammal comprising administering an effective dose of a composition comprising an active ingredient selected from...
|
|
|
5985330 |
Inhibition of angiogenesis by sea cucumber fractions
The present invention provides inhibition of angiogenesis in a warm-blooded animal by the administration of preparations isolated from the echinoderm sea cucumber (Class Holothuroidea). This...
|
|
|
5985826 |
Methods of using hepatic-directed compounds in pretargeting strategies
Hepatic-directed compounds, reagents useful in making such compounds and associated methods and compositions are disclosed. Hepatic-directed compounds are processed by metabolic mechanisms, which...
|
|
|
5932554 |
1-galactose derivatives
Disclosed are novel 1-galactose derivatives which inhibit binding of toxins, such as heat-labile enterotoxin or cholera toxin, to their receptors either in vitro or in vivo. Additionally, disclosed...
|
|
|
5883079 |
Method for inhibiting H. pylori infection in mammalian tissue
A method for treating and/or inhibiting gastric and duodenal ulcers, comprising administering a pharmaceutical composition comprising an oligosaccharide of Formula I ...
|
|
|
5880111 |
Therapeutic derivations of diphosphonates
Novel chemotherapeutic agents having utility in treating infectious diseases such as periodontal disease, certain urinary tract infections, and infectious urinary tract stones, are obtained by...
|
|
|
5849274 |
Stable light protection preparations containing surface-active glucose derivatives and water-soluble UV filters
Cosmetic or pharmaceutical O/W emulsions which contain (a) one or more surface-active substances selected from the group consisting of glucose derivatives of the structural formula ##STR1## in...
|
|
|
5846548 |
Combined administration of mitogenic immumo stimulator and a thymomimetic
A method of tumor therapy involves controlling the immune system by co-administration of a mitogenic immuno-stimulating substance and a thymomimetic substance.
|
|
|
5846943 |
Solid support matricles containing a toxin binding oligosaccharide
Disclosed are novel solid support matrices having a toxin-binding oligosaccharide covalently attached to a solid support through a linking arm which has at least 8 atoms separating the...
|
|
|
5840702 |
Cystic fibrosis treatment
The present invention provides a method of stimulating expression of a functional full-length cystic fibrosis transmembrane conductance regulator protein in an individual in need of such treatment,...
|
|
|
5837689 |
Sialyl lewis-x mimetics containing naphthyl backbones
Compounds that possess selectin binding activity are described that have a three-dimensionally stable configuration for sialic acid and fucose, or analogs, derivatives, or mimics of these groups,...
|
|
|
5817634 |
Methods of treating diabetes mellitus and clycogen storage disease
This present invention provides a method and compounds for priming the incorporation of cellular glucose into an oligosaccharide in a cell comprising administering to the cell a priming amount of a...
|
|
|
RE35904 |
Method and probes for detecting nucleoside transporter and method for producing the probes
The present invention is directed to compounds capable of binding to the es nucleoside transporter of animal cells having the general formula: ##STR1## wherein n is 1-12; E is H, halogen, NH 2 ,...
|
|
|
5811405 |
Multiply fucosylated dicarboxylic acids possessing antiadhesive properties
The invention relates to multiply fucosylated dicarboxylic acid derivatives possessing antiadhesive properties, to a process for preparing them, to their use, and to pharmaceuticals and diagnostic...
|
|
|
5807847 |
Nitrate esters
Aliphatic Nitrate esters having a sulfur or phosphorus atom β or γ to a nitrate group having efficacy as vasodilators are described. Preferred nitrate esters may be synthesized by nitration of a...
|
|
|
5789385 |
Sialyl Lewis.sup.x mimetics containing phenyl backbones
Compounds that possess selectin binding activity are described that have a three-dimensionally stable configuration for sialic acid and fucose, or analogs, derivatives, or mimics of these groups,...
|
|
|
5773424 |
Treatment of toxoplasmosis
Pharmaceutical compositions comprising a pharmaceutical composition comprising a compound which is an α or β anomer, a D(+) or L(-) enantiomer of the following structural formula: ##STR1##...
|
|
|
5770585 |
Homogeneous water-in-perfluorochemical stable liquid dispersion for administration of a drug to the lung of an animal
This invention is directed to a homogenous water-in-perfluorochemical stable liquid dispersion for acceptable therapeutic administration of a drug to the lung of an animal. The dispersion includes...
|
|
|
5767093 |
Methods for attenuating antibody-mediated xenograft rejection in human recipients
Antibody-mediated xenograft rejection is attenuated by parenterally administering a xenoantibody-inhibiting amount of an identified carbohydrate xenoantigen to the recipient shortly before graft...
|
|
|
5753630 |
Method for treating and inhibiting gastric and duodenal ulcers
A method for treating and/or inhibiting gastric and duodenal ulcers, comprising administering a pharmaceutical composition comprising an oligosaccharide of Formula I ...
|
|
|
5750508 |
Sialic acid/fucose based medicaments
Compounds that are synthetically inexpensive to make relative to the naturally occurring selectin ligands and that retain selectin binding activity are described that have a three-dimensionally...
|
|
|
5739115 |
Sulfated maltooligosaccharides with heparin-like properties
A novel class of highly sulfated maltooligosaccharide having heparin-like activity is described, as well as methods for using these oligosaccharides to treat certain diseases including cancer, and...
|
|
|
5733886 |
Compositions of clindamycin and benzoyl peroxide for acne treatment
Compositions suitable for the treatment of acne by topical application comprise clindamycin and benzoyl peroxide. Kits for preparing the compositions include a solution of clindamycin in a first...
|
|
|
5719192 |
Use of terbinafine for the therapeutic treatment of pneumocystosis
A method of use comprising administering terbinafine for the primary and secondary prophylaxis and treatment of Pneumocystis carinii pneumonia, including oral administration of terbinafine at does...
|
|
|
5707653 |
Ulcer treating composition comprising sufalcrate and antibiotic
Pharmaceutical compositions comprising an antibiotic adsorbed onto a disaccharide polysulfate-aluminum compound such as sucralfate are effective for the treatment of ulcers. The composition...
|
|
|
5702694 |
Compositions for treating corns, calluses and warts
Topical compositions for the treatment of corns, calluses and warts comprising a benzenediol or a substituted 1,2-benzenediol and a pharmaceutically acceptable carrier, are described.
|
|
|
5700784 |
External preparation for skin
An external preparation for the skin comprising at least one of the glycosides or hydroxysaliyclic acid and/or the glycosides of aliphatic esters of hydroxysalicylic acid represented by the...
|
|
|
5677285 |
Derivatives of neuraminic acid
Provided are new derivatives of neuraminic acid of formula (I), where Ac represents an acyl residue of an aliphatic, araliphatic, aromatic, alicyclic, or heterocyclic carboxylic acid, including...
|
|
|
5665707 |
Treatment for toxoplasmosis with a composition comprising a lincosamide and a spiropiperidyl derivative of rifamycik S
A method of reducing the severity of toxoplasmosis resulting from infection of a patient with Toxoplasma gondii by administering to a patient in need of such treatment, either after infection or...
|